Salivary Gland Pathology in Sjögren's Syndrome
- PMID: 27431349
- DOI: 10.1016/j.rdc.2016.03.006
Salivary Gland Pathology in Sjögren's Syndrome
Abstract
Primary Sjögren syndrome (pSS) can be considered a systemic autoimmune disease with a strong organ bias. The involvement of the exocrine glands is prevalent and drives the pathognomonic manifestations of dryness that define the sicca syndrome. The salivary glands also represent the hub of pSS pathology. Elements belonging to both innate and acquired immune responses have been described at this site that contribute to disease establishment and progression. The interaction between those elements and their relative contributions to the clinical manifestations and lymphoma progression largely remain to be addressed.
Keywords: Autoimmune disease; Histopathology; Primary Sjögren's syndrome; Salivary glands.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Autoantigen-specific B cells and plasma cells are prominent in areas of fatty infiltration in salivary glands of patients with primary Sjögren's syndrome.Autoimmunity. 2019 Nov-Dec;52(7-8):242-250. doi: 10.1080/08916934.2019.1684475. Epub 2019 Oct 30. Autoimmunity. 2019. PMID: 31661985
-
B-lymphocytes govern the pathogenesis of Sjögren's syndrome.Curr Pharm Biotechnol. 2012 Aug;13(10):2071-7. doi: 10.2174/138920112802273100. Curr Pharm Biotechnol. 2012. PMID: 22208653 Review.
-
B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF.Autoimmun Rev. 2010 Jul;9(9):604-8. doi: 10.1016/j.autrev.2010.05.006. Epub 2010 May 8. Autoimmun Rev. 2010. PMID: 20457281 Review.
-
Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome.Arthritis Rheum. 2006 Jul;54(7):2280-8. doi: 10.1002/art.21936. Arthritis Rheum. 2006. PMID: 16802367
-
Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren's syndrome.J Autoimmun. 2014 Jun;51:57-66. doi: 10.1016/j.jaut.2013.11.003. Epub 2014 Jan 9. J Autoimmun. 2014. PMID: 24411167
Cited by
-
14-3-3η Proteins as a Diagnostic Marker, Disease Activation Indicator, and Lymphoma Predictor in Patients with Primary Sjögren Syndrome.Arch Iran Med. 2023 Oct 1;26(10):582-591. doi: 10.34172/aim.2023.85. Arch Iran Med. 2023. PMID: 38310415 Free PMC article.
-
Pulmonary Manifestations of Primary Sjögren's Syndrome: Underlying Immunological Mechanisms, Clinical Presentation, and Management.Front Immunol. 2019 Jun 12;10:1327. doi: 10.3389/fimmu.2019.01327. eCollection 2019. Front Immunol. 2019. PMID: 31249572 Free PMC article. Review.
-
Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome.Ann Rheum Dis. 2019 Feb;78(2):249-260. doi: 10.1136/annrheumdis-2017-212619. Epub 2018 Nov 24. Ann Rheum Dis. 2019. PMID: 30472652 Free PMC article.
-
Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren's syndrome that show potential to predict and monitor clinical response.RMD Open. 2023 Aug;9(3):e002979. doi: 10.1136/rmdopen-2023-002979. RMD Open. 2023. PMID: 37532471 Free PMC article.
-
Bioinformatics Analysis for Identification of Key Genes in Salivary Gland and the Potential of a Combination of Biomarkers for the Diagnosis of SS.J Inflamm Res. 2021 Aug 25;14:4143-4153. doi: 10.2147/JIR.S322318. eCollection 2021. J Inflamm Res. 2021. PMID: 34475773 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical